Pharma chief casts doubt on Roche interest in Alexion

Eric Palmer Today Roche pharma chief Daniel O'Day threw cold water on the speculation. As FierceBiotech reports, he told Reuters' Ben Hirschler that ultra-rare diseases just ...

Roche pharma chief douses hot rumors on Alexion buyout

John Carroll Maybe Roche ($ RHBBY) isn't as interested in Alexion Pharmaceuticals ($ ALXN) as some recent news reports suggest. Roche pharma chief Daniel O'Day told Reuters ...

Roche won’t pursue Herceptin patents in India

Carly Helfand Roche is throwing in the towel on its IP protection for Herceptin in India. As PharmAsia News reports, the company will give up its patents for Herceptin there, a move ...

Roche chief’s comments about deal discipline push shares up

Tracy Staton After Roche chief Severin Schwan said over the weekend that deals have to be "worth it financially," Notenstein analysts added that to their checklist of evidence ...

Roche Launches GS FLX+ System Software Update

barbara.lempert Roche Launches GS FLX+ System Software Update to Extend Read Lengths for Targeted Gene Sequencing and Microbial Community Profiling Studies The latest Software Version ...

Roche Wants NJ Supreme Court To Remove Accutane Judge

esilverman Once again, Roche is trying to remove a New Jersey judge from the sprawling Accutane litigation. After being rebuffed earlier this year when Superior Court Judge ...

Roche throws HIV blindness drug Valcyte into patent pool

Carly Helfand Roche has signed an agreement with the Medicines Patent Pool to surrender Valcyte's patent and make the drug available in developing countries by slashing costs by ...

Report: Alexion taps financial advisers for potential Roche deal

Tracy Staton Bloomberg has revived speculation about a potential acquisition of Alexion, reporting that Alexion has brought in Goldman Sachs to advise the company after Roche made an ...

Report: Alexion allies with Goldman as Roche buyout rumor blazes

John Carroll If Roche actually comes through with a $ 22 billion-plus bid for Alexion, the biotech intends to be ready to man the defenses and fight it out for top dollar. FierceBiotech ...

Roche First Half Net Up 10%

barbara.lempert Roche posts strong first-half results Group sales 5%1 higher at 23.3 billion Swiss francs Core EPS 12% higher at 7.58 Swiss francs; net income rose to ...

Roche highlights more upbeat PhIII data for ‘breakthrough’ leukemia contender

Ryan McBride FierceBiotech News

Roche casts its net (again) for the perfect chairman

Carly Helfand Roche needs a new chairman, and the candidates aren't exactly lining up. With its top two choices having already declined the position, the Swiss drug giant may have ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS